Commission Removes Warning Signs Relating To Four EU MDR Notified Bodies
Executive Summary
There had been handful of warning signals against well-known notified bodies designated against the MDR. Why were they there and why have they just been removed?
You may also be interested in...
EU Regulatory Roundup, September 2023: Dismantling Regulatory Barriers To Medtech Innovation
The call for more to be done about the EU’s regulatory hurdles to innovation, as well as for improvements to governance, has now grown to a crescendo. While the EU looks at how best to move forward, innovation in the UK is benefiting from greater regulatory freedoms.
Commission Text Clarifying Timelines For Annex XVI Devices May Leave Companies Dazed
The revised timelines around products generally used for aesthetic purposes, a small subset of products falling under the Medical Device Regulation, create their own microsphere of complexity.
Report on Generating And Assessing Evidence To Optimize MDR And IVDR Due In 2024
Recent meeting at Ernst &Young in Brussels outlines steps ahead and likely timelines for gathering information instrumental in shaping recommendations for the future of the MDR/IVDR and their governance structures.